Sean Ewings

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial

Nathan J. Brendish, Ahalya Malachira, Lawrence Armstrong et al. · The Lancet Respiratory Medicine · 2017 · 306 citations · Full text

Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial

Dean A. Fennell, Sean Ewings, Christian H. Ottensmeier et al. · The Lancet Oncology · 2021 · 251 citations · Full text

Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study

Nathan J. Brendish, Stephen Poole, Vasanth V Naidu et al. · The Lancet Respiratory Medicine · 2020 · 132 citations · Full text

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

Saye Khoo, Richard J. Fitzgerald, Sean Ewings et al. · Journal of Antimicrobial Chemotherapy · 2021 · 111 citations · Full text

A web-based intervention (RESTORE) to support self-management of cancer-related fatigue following primary cancer treatment: a multi-centre proof of concept randomised controlled trial

Claire Foster, Chloe Grimmett, Christine May et al. · Supportive Care in Cancer · 2015 · 93 citations · Full text